Carni-Q-Nol (CarniQ-Nol) Male Fertility Formula Review: Evidence, Value & Limitations
Our verdict: A research/historical review is appropriate, but avoid an active purchase recommendation absent a trustworthy current manufacturer offer and current Supplement Facts. Anyone seeking a carnitine/ubiquinol regimen should discuss evidence and exact dose with a clinician. This research review identifies the actual product, measurable results, manufacturer support, and the limitations of claims. We did not personally use or clinically test this product.
Carni-Q-Nol (CarniQ-Nol) Male Fertility Formula — Buyer’s Snapshot
Main differentiator: At two softgels daily the trial regimen contained L-carnitine fumarate 880 mg and ubiquinol 60 mg; at three, 1,320 mg and 90 mg respectively. The study was small and not a robust randomized placebo-controlled live-birth trial. Current availability, quality controls, warranty and price should not be asserted from historic papers.
Product identification and specifications
| Name | Carni-Q-Nol (CarniQ-Nol) Male Fertility Formula |
|---|---|
| Brand | Tishcon / Carni-Q-Nol |
| Category | Male fertility nutrition |
| Verified configuration | Legacy softgel studied with L-carnitine fumarate 440 mg, ubiquinol 30 mg, vitamin E 75 IU and vitamin C 12 mg per softgel; current US retail SKU not reliably confirmed. |
| Source | Original manufacturer, FDA or scientific documentation |
What differentiates this specific product?
A published 2015 study enrolled 40 men with infertility, providing two or three softgels daily and measuring oxidative-stress and semen-biomarker changes. The per-capsule amount refers to L-carnitine fumarate 440 mg, not 440 mg elemental free L-carnitine; confusing ingredient salt mass with active carnitine amount would inflate comparisons.
At two softgels daily the trial regimen contained L-carnitine fumarate 880 mg and ubiquinol 60 mg; at three, 1,320 mg and 90 mg respectively. The study was small and not a robust randomized placebo-controlled live-birth trial. Current availability, quality controls, warranty and price should not be asserted from historic papers.
Evidence review and clinical limitations
This has genuine finished-formula human research, but the 40-patient observational nature, biomarkers and limited comparison group create major limits. Do not treat pregnancy observations in a small selected cohort as proof of a causal live-birth benefit, and do not imply it compares favorably with larger trials of unrelated products.
The AUA/ASRM guideline says clinical benefits of antioxidants and vitamins for male infertility remain questionable. Even a change in sperm motility or oxidative-stress biomarkers does not necessarily establish higher chances of conception or live birth. Treat evidence for a finished formula and ingredient studies separately.
Costs, packaging, support and practical use
A research/historical review is appropriate, but avoid an active purchase recommendation absent a trustworthy current manufacturer offer and current Supplement Facts. Anyone seeking a carnitine/ubiquinol regimen should discuss evidence and exact dose with a clinician.
Before buying, confirm exact serving or disposable-test count, regional seller and any repeat purchases, shipping and app compatibility if applicable. For products with uncertain current stock, avoid making up a promotional sale price or promising official manufacturer support.
Comparison with alternatives
Androferti supplies 1,500 mg daily L-carnitine tartrate with 20 mg CoQ10, while Carni-Q-Nol’s cited daily softgel regimen includes ubiquinol 60–90 mg and different carnitine chemistry. Doses are not chemically interchangeable without calculation.
| Decision factor | Product-specific assessment |
|---|---|
| Primary role | Legacy softgel studied with L-carnitine fumarate 440 mg, ubiquinol 30 mg, vitamin E 75 IU and vitamin C 12 mg per softgel; current US retail SKU not reliably confirmed. |
| Biggest difference | At two softgels daily the trial regimen contained L-carnitine fumarate 880 mg and ubiquinol 60 mg; at three, 1,320 mg and 90 mg respectively. The study was small and not a robust randomized placebo-controlled live-birth trial. Current availability, quality controls, warranty and price should not be asserted from historic papers. |
| Other options | Androferti supplies 1,500 mg daily L-carnitine tartrate with 20 mg CoQ10, while Carni-Q-Nol’s cited daily softgel regimen includes ubiquinol 60–90 mg and different carnitine chemistry. Doses are not chemically interchangeable without calculation. |
Safety and interpretation
Avoid unverified old stock; review CoQ10 interactions such as altered warfarin response. A supplement study cannot replace medical evaluation of infertility.
If you are trying to conceive and a semen test is abnormal or you have had persistent difficulty conceiving, consult a qualified clinician. Do not delay evaluation because of reassuring marketing or a single home result.
Editorial verdict
A research/historical review is appropriate, but avoid an active purchase recommendation absent a trustworthy current manufacturer offer and current Supplement Facts. Anyone seeking a carnitine/ubiquinol regimen should discuss evidence and exact dose with a clinician. This has genuine finished-formula human research, but the 40-patient observational nature, biomarkers and limited comparison group create major limits. Do not treat pregnancy observations in a small selected cohort as proof of a causal live-birth benefit, and do not imply it compares favorably with larger trials of unrelated products.
Frequently Asked Questions
What exactly is this product?
Legacy softgel studied with L-carnitine fumarate 440 mg, ubiquinol 30 mg, vitamin E 75 IU and vitamin C 12 mg per softgel; current US retail SKU not reliably confirmed.
What is the strongest buying distinction?
At two softgels daily the trial regimen contained L-carnitine fumarate 880 mg and ubiquinol 60 mg; at three, 1,320 mg and 90 mg respectively. The study was small and not a robust randomized placebo-controlled live-birth trial. Current availability, quality controls, warranty and price should not be asserted from historic papers.
What evidence is available?
This has genuine finished-formula human research, but the 40-patient observational nature, biomarkers and limited comparison group create major limits. Do not treat pregnancy observations in a small selected cohort as proof of a causal live-birth benefit, and do not imply it compares favorably with larger trials of unrelated products.
What does it cost over time?
A research/historical review is appropriate, but avoid an active purchase recommendation absent a trustworthy current manufacturer offer and current Supplement Facts. Anyone seeking a carnitine/ubiquinol regimen should discuss evidence and exact dose with a clinician.
How does it compare with alternatives?
Androferti supplies 1,500 mg daily L-carnitine tartrate with 20 mg CoQ10, while Carni-Q-Nol’s cited daily softgel regimen includes ubiquinol 60–90 mg and different carnitine chemistry. Doses are not chemically interchangeable without calculation.
Is it a substitute for infertility diagnosis?
No. Nutritional supplementation cannot diagnose or reliably treat every cause of impaired sperm quality.
What are its limitations or safety issues?
Avoid unverified old stock; review CoQ10 interactions such as altered warfarin response. A supplement study cannot replace medical evaluation of infertility.
Sources and Editorial Methodology
Research reviewed November 21, 2026. Documentation ratings evaluate clarity of original evidence rather than the chance of conception. We make no claim of personal product testing, original human research or laboratory assays.